Three-dose hepatitis-B vaccine regimen protects people with HIV: NIH
Finding is part of an ongoing clinical trial
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Dynavax Technologies
Biological E. to begin Phase III trial of COVID-19 vaccine
The company plans to produce 75 million to 80 million doses a month from August